Federated Hermes
ARRY

Federated Hermes’s Array Biopharma Inc ARRY Stock Holding History

Federated Hermes’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-839
Closed -$39K – 2364
2019
Q2 		$39K Sell
839
-562,192
-100% -$15.8M ﹤0.01% 1714
2019
Q1 		$13.7M Buy
563,031
+561,991
+54,038% +$11.7M 0.03% 450
2018
Q4 		$15K Sell
1,040
-40,181
-97% -$609K ﹤0.01% 1813
2018
Q3 		$627K Sell
41,221
-20,122
-33% -$308K ﹤0.01% 1449
2018
Q2 		$1.03M Buy
61,343
+178
+0.3% +$2.83K ﹤0.01% 1280
2018
Q1 		$998K Buy
61,165
+60,062
+5,445% +$962K ﹤0.01% 1227
2017
Q4 		$14K Sell
1,103
-29
-3% -$330 ﹤0.01% 1830
2017
Q3 		$14K Sell
1,132
-72
-6% -$669 ﹤0.01% 1798
2017
Q2 		$10K Sell
1,204
-324
-21% -$2.65K ﹤0.01% 1844
2017
Q1 		$13K Sell
1,528
-150
-9% -$1.6K ﹤0.01% 1788
2016
Q4 		$15K Buy
1,678
+1,316
+364% +$9.68K ﹤0.01% 1791
2016
Q3 		$2K Hold
362
– – ﹤0.01% 2040
2016
Q2 		$1K Sell
362
-18,778
-98% -$61.2K ﹤0.01% 2072
2016
Q1 		$56K Hold
19,140
– – ﹤0.01% 1659
2015
Q4 		$81K Hold
19,140
– – ﹤0.01% 1587
2015
Q3 		$87K Hold
19,140
– – ﹤0.01% 1589
2015
Q2 		$138K Buy
+19,140
New +$141K ﹤0.01% 1553

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Federated Hermes's ARRY Position: Q3 2019 in Review

Federated Hermes sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 839 shares — an estimated $39K sold.

Federated Hermes first reported a position in ARRY in Q2 2015 and held it in 17 quarters. The position peaked at $13.7M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Federated Hermes reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Federated Hermes sold 839 Array Biopharma Inc shares in Q3 2019, an estimated $39K.
  • Federated Hermes first reported a position in Array Biopharma Inc in Q2 2015 and held it in 17 quarters.
  • Federated Hermes's Array Biopharma Inc position peaked at $13.7M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.